A top-five shareholder in struggling Covid-19 vaccine maker Novavax is calling for an “urgent shake-up” of the board and an overhaul of its sales strategy, as the stock is down 99 per cent from its pandemic peak.
陷入困境的新冠疫苗制造商Novavax的五大股东之一呼吁对董事会进行“紧急改组”，并彻底改革其销售战略。该公司股价已从疫情高峰期下跌99%。
您已阅读5%（283字），剩余95%（5621字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。